Cutera, a leading provider of aesthetic and dermatology solutions, has initiated a restructuring transaction and will emerge from Chapter 11 bankruptcy as a privately held company.WHO: Headquartered in Brisbane, CA, Cutera was founded in 1998, and has grown into a leading provider of aesthetic and dermatology solutions for medical professionals worldwide. Cutera’s product suite focuses on four primary dermatology and aesthetic treatment categories: face & skin revitalization, body contouring, and acne. Cutera also offers platforms for tattoo and hair removal treatments. Beyond its core devices, Cutera offers service and support, along with consumables integral to its product platforms. The company maintains direct sales and service operations across 11 countries outside the US and distributes products in over 30 additional international markets. The company went public in 2020 trading under NASDAQ: CUTR.WHY: In recent years, Cutera experienced a series of operational and market-driven challenges, significantly impacting its financial performance. Operational issues included unsuccessful product launches, high executive and board turnover, and the termination of a critical skincare distribution partnership in Japan. Increased competition in the aesthetic medical device market and macroeconomic factors further exacerbated the company's financial pressures. These challenges were intensified by the company's burdensome capital structure, characterized by annual debt service obligations of approximately $12 million, and looming maturities, notably the $69 million senior notes due in March 2026.